
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4959650
[patent_doc_number] => 20080274075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Poly(Ethylene Glycol) Derivatives and Process For Their Coupling to Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/914850
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13657
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274075.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914850 | Poly(Ethylene Glycol) Derivatives and Process For Their Coupling to Proteins | May 18, 2006 | Abandoned |
Array
(
[id] => 5760662
[patent_doc_number] => 20060211607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Somatostatin-dopamine chimeric analogs'
[patent_app_type] => utility
[patent_app_number] => 11/434273
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9086
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211607.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434273
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434273 | Somatostatin-dopamine chimeric analogs | May 14, 2006 | Issued |
Array
(
[id] => 6467210
[patent_doc_number] => 20100040607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/920296
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32945
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040607.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920296 | Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases | May 10, 2006 | Abandoned |
Array
(
[id] => 5446935
[patent_doc_number] => 20090048161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Cytokine receptor modulators and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/919941
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 44931
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048161.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919941 | Cytokine receptor modulators and uses thereof | May 4, 2006 | Abandoned |
Array
(
[id] => 9882751
[patent_doc_number] => 08969516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Method of hydrolysis of peptide bond'
[patent_app_type] => utility
[patent_app_number] => 12/223851
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 11677
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12223851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223851 | Method of hydrolysis of peptide bond | May 3, 2006 | Issued |
Array
(
[id] => 5242854
[patent_doc_number] => 20070021349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Orthogonally protected bifunctional amino acid'
[patent_app_type] => utility
[patent_app_number] => 11/410283
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14042
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410283
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410283 | Orthogonally protected bifunctional amino acid | Apr 24, 2006 | Abandoned |
Array
(
[id] => 5678329
[patent_doc_number] => 20060183685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'PEPTIDE PHARMACEUTICAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/379893
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8743
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183685.pdf
[firstpage_image] =>[orig_patent_app_number] => 11379893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/379893 | PEPTIDE PHARMACEUTICAL FORMULATIONS | Apr 23, 2006 | Abandoned |
Array
(
[id] => 5923911
[patent_doc_number] => 20060241024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Intermediate for preparing glycopeptide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/405234
[patent_app_country] => US
[patent_app_date] => 2006-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29998
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241024.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405234 | Intermediate for preparing glycopeptide derivatives | Apr 16, 2006 | Issued |
Array
(
[id] => 820690
[patent_doc_number] => 07408023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-05
[patent_title] => 'Peptoids incorporating chemoselective functionalities'
[patent_app_type] => utility
[patent_app_number] => 11/398576
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 11027
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/408/07408023.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398576
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398576 | Peptoids incorporating chemoselective functionalities | Apr 3, 2006 | Issued |
Array
(
[id] => 5672940
[patent_doc_number] => 20060178295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Steroid conjugates, preparation thereof and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/398022
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7450
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178295.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398022 | Steroid conjugates, preparation thereof and the use thereof | Apr 3, 2006 | Issued |
Array
(
[id] => 5367310
[patent_doc_number] => 20090304869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Peptides Having an Ace Inhibiting Effect'
[patent_app_type] => utility
[patent_app_number] => 11/919392
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7623
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919392 | Peptides Having an Ace Inhibiting Effect | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5465688
[patent_doc_number] => 20090325888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Peptides having a health benefit and compositions comprising them'
[patent_app_type] => utility
[patent_app_number] => 11/919310
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10451
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325888.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919310 | Peptides having a health benefit and compositions comprising them | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5374709
[patent_doc_number] => 20090312270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Peptides having an ace inhibiting effect'
[patent_app_type] => utility
[patent_app_number] => 11/919448
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7587
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312270.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919448 | Peptides having an ace inhibiting effect | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5575949
[patent_doc_number] => 20090143311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Compositions comprising tripeptides inhibiting ace'
[patent_app_type] => utility
[patent_app_number] => 11/919447
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16749
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919447 | Compositions comprising tripeptides inhibiting ace | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5265487
[patent_doc_number] => 20090118172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Shortened glucagon-like peptide 1(sglp-1) preparation method and application'
[patent_app_type] => utility
[patent_app_number] => 11/665277
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3413
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665277 | Shortened glucagon-like peptide 1(sGLP-1) preparation method and application | Mar 29, 2006 | Issued |
Array
(
[id] => 11176915
[patent_doc_number] => 09408891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Methods of using gelsolin to treat or prevent bacterial sepsis'
[patent_app_type] => utility
[patent_app_number] => 11/391540
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 18209
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11391540
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/391540 | Methods of using gelsolin to treat or prevent bacterial sepsis | Mar 27, 2006 | Issued |
Array
(
[id] => 5672959
[patent_doc_number] => 20060178314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods and compositions for treating atheroma, tumors and other neoplastic tissues'
[patent_app_type] => utility
[patent_app_number] => 11/388385
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15952
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388385
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388385 | Methods and compositions for treating atheroma, tumors and other neoplastic tissues | Mar 23, 2006 | Issued |
Array
(
[id] => 5596809
[patent_doc_number] => 20060160727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => '3-Ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection'
[patent_app_type] => utility
[patent_app_number] => 11/386291
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19128
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386291 | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection | Mar 20, 2006 | Issued |
Array
(
[id] => 798070
[patent_doc_number] => 07427657
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-23
[patent_title] => 'Aromatic sulfenates for type 1 phototherapy'
[patent_app_type] => utility
[patent_app_number] => 11/276971
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 4666
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11276971
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/276971 | Aromatic sulfenates for type 1 phototherapy | Mar 19, 2006 | Issued |
Array
(
[id] => 5107070
[patent_doc_number] => 20070065948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Use of antibody-surrogate antigen systems for detection of analytes'
[patent_app_type] => utility
[patent_app_number] => 11/375825
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11568
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375825 | Use of antibody-surrogate antigen systems for detection of analytes | Mar 14, 2006 | Abandoned |